VISION HEALTHCARE
0685.849.188 · rovalta.com · 26/09/2026
ACTIVE
VISION HEALTHCARE
Financial year 2025 · Closed on 31/12/2025
Net result11,6 M €+295,5 %over 1 year
Revenue14,3 M €+19,6 %over 1 year
Equity153,7 M €+25,4 %over 1 year
Overview
Identity
Source · BCE/KBOVISION HEALTHCARE is a Public limited company incorporated in 2017. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Wevelgem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0685.849.188
- Incorporation
- 12/12/2017
- Legal form
- Public limited company
- Registered office
- Nijverheidslaan 3
8560 Wevelgem · FlandreSee on map - Contributed capital
- 162 813 728,67 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowHigh revenue
Financials
Source · NBB, 10 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 14,3 M € | +19.6% | 12 M € | +4.8% | 11,4 M € | +1.7% | 11,2 M € | +18.4% | 9,5 M € |
| EBITDA | -2 M € | -86.0% | -1,1 M € | +33.1% | -1,6 M € | -240% | -478,8 k € | +31.3% | -697,2 k € |
| Operating result | -2 M € | -80.2% | -1,1 M € | +30.2% | -1,6 M € | -813% | -178,4 k € | +82.1% | -997,6 k € |
| Net result | 11,6 M € | +296% | -5,9 M € | -198% | -2 M € | -239% | 1,4 M € | +110% | -14,8 M € |
| Balance sheet | |||||||||
| Equity | 153,7 M € | +25.4% | 122,6 M € | -4.6% | 128,5 M € | -1.5% | 130,5 M € | +8.7% | 120 M € |
| Total assets | 283,8 M € | +11.8% | 253,9 M € | -6.1% | 270,3 M € | -1.6% | 274,8 M € | +11.3% | 246,9 M € |
| Cash | 8,2 € | -91.0% | 91,2 € | -100.0% | 6,4 M € | -20.0% | 8 M € | +127% | 3,5 M € |
| Debts | 127,3 M € | -1.7% | 129,4 M € | -5.9% | 137,5 M € | -3.1% | 141,8 M € | +12.1% | 126,5 M € |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 M€ and 250 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Nijverheidslaan 3 8560 Wevelgem| Company | CBE no. |
|---|---|
ALPHA FOODS● Active | 0745.397.092 |
PURASANA● Active | 0438.537.691 |
Vision CHC● Active | 0747.498.331 |
Vision Consumer Health● Active | 0747.499.618 |
Vision HC● Active | 0747.496.549 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/06/2026 | 15/05/2025 | 23/08/2024 | 21/08/2023 | 01/06/2022 | 16/06/2021 |
| General meeting | 30/04/2026 | 30/04/2025 | 18/04/2024 | 20/04/2023 | 20/05/2022 | 21/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 30/04/2026 | 22/06/2026 | Dutch | |
| Full model | 31/12/2024 | 30/04/2025 | 15/05/2025 | Dutch | |
| Full model | 31/12/2023 | 18/04/2024 | 23/08/2024 | Dutch | |
| Full model | 31/12/2022 | 20/04/2023 | 21/08/2023 | Dutch | |
| Full model | 31/12/2021 | 20/05/2022 | 01/06/2022 | Dutch | |
| Full model | 31/12/2020 | 21/04/2021 | 16/06/2021 | Dutch | |
| Full model | 31/12/2019 | 24/04/2020 | 25/05/2020 | Dutch | |
| Consolidated accounts | 31/12/2019 | 24/04/2020 | 25/05/2020 | Dutch | |
| Full model | 31/12/2018 | 27/06/2019 | 18/07/2019 | Dutch | |
| Consolidated accounts | 31/12/2018 | 12/07/2019 | 22/07/2019 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 M€ and 250 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office30/03/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - MAATSCHAPPELIJKE ZETEL
- Registered office03/03/2026MAATSCHAPPELIJKE ZETEL
- Capital / shares07/10/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates31/12/2024ONTSLAGEN - BENOEMINGEN
- Capital / shares20/10/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates30/09/2022ONTSLAGEN - BENOEMINGEN
- Mandates13/12/2021ONTSLAGEN - BENOEMINGEN
- Other19/07/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202511,6 M €↑
- 09/09/2025augmentation_capital
- 09/09/2025augmentation_capital
- 09/09/2025apportVISION CONSUMER HEALTH
- 2024Annual accounts 2024-5,9 M €↓
- 2023Annual accounts 2023-2 M €↓
- 01/07/2023nominationWouter Coppens — commissaris
- 20/04/2023reconductionPwC Bedrijfsrevisoren BV — commissaris
- 2022Annual accounts 20221,4 M €↑
- 2021Annual accounts 2021-14,8 M €↓
- 30/07/2021nominationPeter Opsomer — commissaris
- 2020Annual accounts 20201,1 M €↑
- 2018Annual accounts 2018-375,2 k €
- 12/12/2017IncorporationPublic limited company